Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Toxicity in the Colon”

39 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 39 results

Testing effectiveness (Phase 2)Study completedNCT05316818
What this trial is testing

Triplet (FOLFOXIRI) vs. Doublet (FOLFOX or FOLFIRI) Regimen as a 1st Line Treatment in Metastatic Colorectal Carcinoma

Who this might be right for
Metastatic Colorectal Cancer
Kasr El Aini Hospital 64
Not applicableStudy completedNCT04528745
What this trial is testing

The Relationship Between Fat Free Mass and Toxicity of Cytostatics in Cancer Patients

Who this might be right for
Pancreas CancerColorectal Cancer
University of Copenhagen 52
Not applicableEnded earlyNCT01934179
What this trial is testing

Telomere Length in Predicting Toxicity in Older Patients With Stage III-IV Colorectal Cancer Undergoing Chemotherapy

Who this might be right for
Mucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the RectumSignet Ring Adenocarcinoma of the Colon+9 more
Fox Chase Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT00748215
What this trial is testing

Calcium Aluminosilicate Anti-Diarrheal in Treating and Preventing Diarrhea in Patients With Metastatic Colorectal Cancer Receiving Irinotecan

Who this might be right for
Chemotherapeutic Agent ToxicityColorectal CancerDiarrhea
M.D. Anderson Cancer Center 100
Not applicableStudy completedNCT04799080
What this trial is testing

Chemotherapy-induced Peripheral Neuropathy (CIPN) on Motor and Sensory Function

Who this might be right for
CancerChemotherapy-induced Peripheral NeuropathyChemotherapeutic Toxicity+4 more
Izmir Bakircay University 72
Large-scale testing (Phase 3)Study completedNCT00075868
What this trial is testing

Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer

Who this might be right for
Anal CancerColorectal CancerDrug/Agent Toxicity by Tissue/Organ+1 more
Radiation Therapy Oncology Group 233
Post-approval studies (Phase 4)UnknownNCT04269369
What this trial is testing

Implementation of Pre-emptive Geno- and Phenotyping in 5-Fluorouracil- or Capecitabine-treated Patients

Who this might be right for
Colon CancerStomach TumorAnal Tumor+2 more
Jessa Hospital 250
Not applicableLooking for participantsNCT05655780
What this trial is testing

The Role of the Tumor Molecular Profile (CMS), UGT1A1 Genotype and Beta-glucuronidase Activity of the Intestinal Microbiota for Treatment Efficiency, Toxicity, Survival and Quality of Life in Patients With Metastatic or Unresectable Colorectal Cancer During Irinotecan-based Systemic Treatment

Who this might be right for
Colorectal Neoplasms
Maastricht University Medical Center 104
Not applicableLooking for participantsNCT04754672
What this trial is testing

Aerobic Fitness or Muscle Mass Training to Improve Colorectal Cancer Outcome

Who this might be right for
Colorectal CancerChemotherapeutic ToxicitySurvivorship+1 more
Radboud University Medical Center 228
Early research (Phase 1)Study completedNCT01859858
What this trial is testing

Effect of Curcumin on Dose Limiting Toxicity and Pharmacokinetics of Irinotecan in Patients With Solid Tumors

Who this might be right for
Advanced Colorectal Cancer
UNC Lineberger Comprehensive Cancer Center 23
Not applicableStudy completedNCT07177560
What this trial is testing

Topical Diclofenac for Hand-Foot Syndrome Prevention in Colorectal and Gastric Cancer on Capecitabine (DICLO-HFS)

Who this might be right for
Colorectal CancerGastric Cancer (GC)Capecitabine+1 more
Gazi University 151
Not applicableEnded earlyNCT01547923
What this trial is testing

Pre-therapeutic Identification of Dihydropyrimidine Dehydrogenase Gene (DPD) Deficiency for Predicting Toxicity to Fluoropyrimidines

Who this might be right for
Colorectal CancerIntravenous 5 Fluorouracile
Institut Cancerologie de l'Ouest 1,142
Testing effectiveness (Phase 2)Ended earlyNCT00036517
What this trial is testing

Safety Study of the Chemotherapy Modulator PHY906 in Patients With Advanced Colorectal Cancer

Who this might be right for
Colorectal NeoplasmsDiarrhea
PhytoCeutica 30
Not applicableStudy completedNCT01280513
What this trial is testing

Effect of Increased Protein Intake on Colonic Metabolism

Who this might be right for
Protein FermentationToxicity in the Colon
KU Leuven 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT06967155
What this trial is testing

Irinotecan With Dabrafenib Plus Trametinib and Anti-EGFR in the Second Line of Therapy in People With Metastatic Colorectal Cancer

Who this might be right for
Neoplasms
Blokhin's Russian Cancer Research Center 23
Not applicableEnded earlyNCT01466504
What this trial is testing

Effect of Sorafenib or Regorafenib on P63 Expression and Keratinocyte Differentiation in Human Skin

Who this might be right for
Renal Cell CarcinomaHepatocellular CarcinomaColorectal Carcinoma
Dartmouth-Hitchcock Medical Center 4
Large-scale testing (Phase 3)Study completedNCT01918852
What this trial is testing

S-1 Versus Capecitabine in the First Line Treatment of MCC Patients.

Who this might be right for
Colorectal CancerMetastases
Dutch Colorectal Cancer Group 161
Not applicableStudy completedNCT06856590
What this trial is testing

ZINCLO-HAND: Zinc and Clobetasol for the Prevention of Regorafenib-Induced Hand-Foot Skin Reaction

Who this might be right for
Hand-Foot Skin Reaction (HFSR)
Gazi University 150
Testing effectiveness (Phase 2)Study completedNCT01149304
What this trial is testing

Preventive Effect of Enoxaparin, Pentoxifylline and Ursodeoxycholic Acid to Radiation Induced Liver Toxicity

Who this might be right for
Colorectal CancerLiver MetastasesIrradiation Damage+1 more
University of Magdeburg 22
Not applicableStudy completedNCT01170299
What this trial is testing

Low-Fiber Diet or High-Fiber Diet in Preventing Bowel Side Effects in Patients Undergoing Radiation Therapy for Gynecological Cancer, Bladder Cancer, Colorectal Cancer, or Anal Cancer

Who this might be right for
Anal CancerBladder CancerCervical Cancer+6 more
Royal Marsden NHS Foundation Trust 177
Load More Results